Steven Jon Russell - 27 Feb 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Chief Medical Officer
Signature
/s/ Stephen Feider, Attorney-in-Fact
Issuer symbol
BBNX
Transactions as of
27 Feb 2025
Transactions value $
$0
Form type
4
Filing time
03 Mar 2025, 17:45:12 UTC
Previous filing
03 Feb 2025
Next filing
04 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Award $0 +35,000 +92% $0 73,071 27 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBNX Employee Stock Option (right to buy) Award $0 +52,000 $0 52,000 27 Feb 2025 Common Stock 52,000 $19.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
F2 The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.